» Articles » PMID: 36817891

Routine Saliva Testing for SARS-CoV-2 in Children: Methods for Partnering with Community Childcare Centers

Abstract

While considerable attention was placed on SARS-CoV-2 testing and surveillance programs in the K-12 setting, younger age groups in childcare centers were largely overlooked. Childcare facilities are vital to communities, allowing parents/guardians to remain at work and providing safe environments for both children and staff. Therefore, early in the COVID-19 pandemic (October 2020), we established a PCR-based COVID-19 surveillance program in childcare facilities, testing children and staff with the goal of collecting actionable public health data and aiding communities in the progressive resumption of standard operations and ways of life. In this study we describe the development of a weekly saliva testing program and provide early results from our experience implementing this in childcare centers. We enrolled children (aged 6 months to 7 years) and staff at seven childcare facilities and trained participants in saliva collection using video chat technology. Weekly surveys were sent out to assess exposures, symptoms, and vaccination status changes. Participants submitted weekly saliva samples at school. Samples were transported to a partnering clinical laboratory or RT-PCR testing using SalivaDirect and results were uploaded to each participant's online patient portal within 24 h. SARS-CoV-2 screening and routine testing programs have focused less on the childcare population, resulting in knowledge gaps in this critical age group, especially as many are still ineligible for vaccination. SalivaDirect testing for SARS-CoV-2 provides a feasible method of asymptomatic screening and symptomatic testing for children and childcare center staff. Given the relative aversion to nasal swabs in younger age groups, an at-home saliva collection method provides an attractive alternative, especially as a routine surveillance tool. Results can be shared rapidly electronically through participants' private medical chart portals, and video chat technology allows for discussion and instruction between investigators and participants. This study fosters a cooperative partnership with participating childcare centers, parents/guardians, and staff with the goal of mitigating COVID-19 transmission in childcare centers. Age-related challenges in saliva collection can be overcome by working with parents/guardians to conceptualize new collection strategies and by offering parents/guardians continued virtual guidance and support.

Citing Articles

Scalable solutions for global health: the SalivaDirect model.

Wyllie A, Choate B, Burke L, Ali Y Front Cell Infect Microbiol. 2024; 14:1446514.

PMID: 39534700 PMC: 11554656. DOI: 10.3389/fcimb.2024.1446514.


A low-cost culture- and DNA extraction-free method for the molecular detection of pneumococcal carriage in saliva.

Peno C, Lin T, Hislop M, Yolda-Carr D, Farjado K, York A Microbiol Spectr. 2024; 12(9):e0059124.

PMID: 39028185 PMC: 11370248. DOI: 10.1128/spectrum.00591-24.


Magnetic bead-based separation of pneumococcal serotypes.

York A, Huynh E, Mbodj S, Yolda-Carr D, Hislop M, Echlin H Cell Rep Methods. 2023; 3(2):100410.

PMID: 36936076 PMC: 10014298. DOI: 10.1016/j.crmeth.2023.100410.


Saliva-based methods for SARS-CoV-2 testing in low- and middle-income countries.

Tan S, Allicock O, Katamba A, Carrington C, Wyllie A, Armstrong-Hough M Bull World Health Organ. 2022; 100(12):808-814.

PMID: 36466209 PMC: 9706358. DOI: 10.2471/BLT.22.288526.

References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Dhiman N, Miller R, Finley J, Sztajnkrycer M, Nestler D, Boggust A . Effectiveness of patient-collected swabs for influenza testing. Mayo Clin Proc. 2012; 87(6):548-54. PMC: 3538476. DOI: 10.1016/j.mayocp.2012.02.011. View

3.
Tobik E, Kitfield-Vernon L, Thomas R, Steel S, Tan S, Allicock O . Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe. Expert Rev Mol Diagn. 2022; 22(5):519-535. DOI: 10.1080/14737159.2022.2094250. View

4.
McLaughlin H, Worrell M, Malone S, Dawson P, Maricque B, Halpin J . Acceptance of Saliva-Based Specimen Collection for SARS-CoV-2 Testing Among K-12 Students, Teachers, and Staff. Public Health Rep. 2022; 137(3):557-563. PMC: 9109545. DOI: 10.1177/00333549221074395. View

5.
Wyllie A, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P . Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N Engl J Med. 2020; 383(13):1283-1286. PMC: 7484747. DOI: 10.1056/NEJMc2016359. View